| Study ID | Number | Study Title | Institute | Species | Analysis |
|---|---|---|---|---|---|
| ST001201 | 1 metabolites | Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites | Monash University | Plasmodium falciparum;Homo sapiens | MS |
| ST001202 | 1 metabolites | Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites | Monash University | Plasmodium falciparum;Homo sapiens | MS |
| ST001205 | 1 metabolites | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Monash University | Plasmodium falciparum;Homo sapiens | MS |
| ST001274 | 1 metabolites | Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-I) | Monash University | Trypanosoma brucei brucei | MS |
| ST001788 | 1 metabolites | β-Adrenergic regulation of metabolism in macrophages (part-IV) | Monash University | Homo sapiens | MS |
| ST002094 | 1 metabolites | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Mayo Clinic | Homo sapiens | MS |
| ST002792 | 1 metabolites | Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as a cross-species strategy to treat malaria | Monash University | Plasmodium falciparum | MS |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|